Growth Metrics

Exelixis (EXEL) EPS (Weighted Average and Diluted) (2016 - 2026)

Exelixis has reported EPS (Weighted Average and Diluted) over the past 15 years, most recently at $0.88 for Q1 2026.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.88 for Q1 2026, up 83.33% from a year ago — trailing twelve months through Jan 2026 was $2.77 (up 56.5% YoY), and the annual figure for FY2026 was $2.78, up 57.95%.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.88 at Exelixis, up from $0.69 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for EXEL hit a ceiling of $0.88 in Q1 2026 and a floor of -$0.09 in Q4 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.26 (2023), compared with a mean of $0.36.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 130.49% in 2022 and later surged 12166.94% in 2024.
  • Exelixis' EPS (Weighted Average and Diluted) stood at -$0.09 in 2022, then skyrocketed by 400.0% to $0.27 in 2023, then soared by 48.15% to $0.4 in 2024, then surged by 72.5% to $0.69 in 2025, then rose by 27.54% to $0.88 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.88 (Q1 2026), $0.69 (Q4 2025), and $0.65 (Q3 2025) per Business Quant data.